Home

Header Menu

Press Release

Six of Top 10 Pharmaceutical Firms Embrace DYS Analytics to Take Control of their Global Collaboration Networks

Helps Manage Messaging Platforms, Assure Swift Collaboration; Pharmaceutical Firms Attest to IT Teams' Unique Needs for Strong Email Analysis and Reporting Solutions

WELLESLEY MA January 23, 2006 - DYS Analytics, Inc., a privately held firm whose innovative products and services manage today's top messaging platforms, announced that strong sales during fiscal year 2005, including major deployments and projects at Novartis, have given DYS an expanded presence in the pharmaceutical industry. Six of the top 10 pharmaceutical firms in the US , plus other leading international pharmaceutical organizations such as Serono International S.A. and Schering AG, use DYS CONTROL! to optimize their email, IM and eMeetings collaboration services.


With DYS CONTROL!, pharmaceutical IT staff can better cope with the masses of collaborative data that flows throughout the organization during the drug development process. IT can best assure systems operate at peak service levels with lowest total cost of ownership (TCO). Accrued savings can then be allocated toward growing the business. With this efficient infrastructure, development groups have immediate access to critical knowledge and thereby gain competitive advantage. DYS is showcasing its latest CONTROL! solutions today at the Lotusphere show in Orlando in its booth #611.


Pharmaceutical firms rely extensively on collaborative databases, emails, IM conversations and eMeetings to share knowledge efficiently between colleagues and accelerate projects. These collaborative applications must operate flawlessly 7/24 and operate at optimum performance levels or project goals are missed. Yet many pharmaceutical firms' networks have become so large and complex that IT teams are frequently delayed in discovering root causes, cannot swiftly find and correct misuse/abuse that slows performance for all, or are hampered in accurately planning future infrastructure needs.


Leading pharmaceutical firms who have purchased DYS' CONTROL! have found their IT staff now can:

  • Improve Operational Effectiveness - CONTROL! speeds problem detection and resolution of globally deployed messaging and collaborative applications. This includes identifying the handful of users who are most impacting the infrastructure, and proactively working with them to distribute their information efficiently via means other than massive emails.
  • Monitor SLA Compliance by providing objective reports to the business units showing end-to-end delivery times, compliancy as well as getting detailed reports to address SLA issues before they impact contracted terms.
  • Budget Accurately by more accurately planning future capacity needs and budgets. IT no longer has to guess or use outdated assumptions as CONTROL! provides accurate and detailed enterprise-wide reports, trends and analysis on actual use.
  • Maximize Corporate Asset Use through server consolidations, stale database cleanups, faster and more reliable platform upgrades, topology redesigns and streamlined application rollouts. These efforts lower organizational costs, and when done with DYS CONTROL!, minimize or eliminate project risks and organizational impacts.
     

Profile Email/IM Usage, Optimize Server Placement
One DYS Pharmaceutical customer uses CONTROL! to profile email usage, develop policies and best practices and ensure ongoing compliance with these policies. This helps reduce the amount of email sent - imposing less burden on the infrastructure and less burden on the recipients to filter through unnecessary messages.


In another instance, a Pharmaceutical firm halted deployment of additional IBM Lotus Sametime servers in one country when DYS CONTROL! uncovered low Sametime IM traffic there and far greater demand for these services in the US. By locating the additional servers in the US, the firm lowered international WAN costs and ensured optimal Sametime performance in the areas of greatest need - especially as Sametime real-time audio conferencing was being used.


"Pharmaceutical firms are such heavy users of Domino applications, email and IM, that it's easy for their networks to become overrun with traffic that exceeds available CPU, storage and bandwidth capacity," said Andrew Wolff, vice president of products, DYS Analytics. "DYS Analytics helps these firms ensure their messaging and application networks are both high performing and operating at lowest cost."


DYS CONTROL! solutions provide IT managers at pharmaceutical organizations with a deep understanding of their email, instant messaging, e-Meeting and application databases use. Using CONTROL!, IT staff analyze, are alerted on health/availability issues, obtain metric reports on enterprise-wide collaborative application use such as IBM Lotus Notes, Microsoft Exchange, IBM Lotus Sametime and IBM Lotus QuickPlace. Armed with these metrics, IT professionals accelerate strategic projects like platform upgrades, server consolidations, topology redesigns and merger/acquisition-related network changes. By having a complete picture of their traffic, usage and performance, IT staff proactively manage their network, dramatically reduce operational costs and improve messaging performance levels.

 

###


Permessa, Permessa Corporation, DYS Analytics, DYS Analytics, Inc, Control! and the Permessa logo are trademarks of Permessa. IBM, IBM Lotus Notes and Domino, IBM Lotus Sametime, and IBM Lotus Quickr are trademarks of IBM Corporation in the United States, other countries, or both. Microsoft, Microsoft Windows, Microsoft SQL 2000, Microsoft Exchange are trademarks of Microsoft Corporation in the United States, other countries, or both. Other brand and product n IBM, Lotus, Notes and Domino are trademarks of International Business Machines Corporation in the United States, other countries or both. Other company, product and service names may be trademarks or service marks of others names are the registered trademarks or trademarks of their respective owners. Specifications are subject to change without notice.

Permessa Corporation :: +1-781-694-2200 :: Email Press Contact 

 

 

onMessaging

Get latest messaging news and free product offers.
Subscribe now!

Ask a Question

First Name:
*
Last Name:
*
Company:
*
Email:
*
Phone:
Messaging Platform:
*
How large is your site?
*
Your areas of interest?
Email
Instant Messaging
Collaboration
Domino Replication
Consulting Services
Your question or comment: